Cabaser 1 mg
Cabaser 1 mg is a medicine authorised by Swissmedic under authorisation number 53362. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 January 1996 and the authorisation is limited until 30 September 2026. ATC code N04BC06 places the medicine in the group Anti-Parkinson drugs.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cabaser 1 mg, Tabletten | B | 23 January 1996 |
| 2 | Cabaser 2 mg, Tabletten | B | 23 January 1996 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | N04BC06 | 01.08.0. | B |
| 2 | 20 | Tablette(n) | N04BC06 | 01.08.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Cabaser 1 mg authorised in Switzerland?
Yes. Cabaser 1 mg is authorised by Swissmedic under authorisation number 53362, data as of 01 September 2026. The authorisation is limited until 30 September 2026.
Which dispensing category does Cabaser 1 mg have?
Cabaser 1 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Cabaser 1 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.